Modelling overall survival in immunotherapy using parametric techniques : Avelumab in previously treated metastatic Merkel cell carcinoma

Bullement, A. orcid.org/0000-0001-7091-0972, Amin, A., Stapelkamp, C. et al. (5 more authors) (2018) Modelling overall survival in immunotherapy using parametric techniques : Avelumab in previously treated metastatic Merkel cell carcinoma. In: Value in Health. ISPOR 21st Annual European Meeting, 10-14 Nov 2018, Barcelona, Spain. Vol. 21 (Supplement 3). Elsevier, S11-S11. ISSN: 1098-3015. EISSN: 1524-4733.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2018 The Authors. For re-use permissions, please contact the authors.
Dates:
  • Published (online): 24 December 2018
  • Published: October 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield)
Date Deposited: 03 Feb 2021 14:31
Last Modified: 04 Feb 2021 22:34
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.jval.2018.09.062
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)